In our study, these ER low positive tumors presented a higher Ki-67 labeling index than ER > 10% positive tumors, but similar to ER-negative tumors, which showed that ER low positive tumors may have distinct characteristics that differ from the usual ER-positive cancers. This evidence concerns the gene ESR1 and cancer.